vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems
Covered in this story
Call it yourself
No calls on $VTVT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on vTv Therapeutics →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.